IngredientsThe common name dense fruit dittany is applied in the herb trade and supplement marketplace to at least two botanically distinct plants belonging to entirely different plant families. Understanding this distinction is essential for accurate interpretation of any research or traditional data.
Dictamnus dasycarpus Turcz. (scientific name) is the plant most commonly sold in the Chinese herbal medicine market under the common names Dense Fruit Dittany Root Bark, Dictamnus Root Bark, and Chinese Dittany Root Cortex, with the Chinese name 白鲜皮 (Bai Xian Pi). It belongs to the family Rutaceae, and the parts used are the barks. Dictamnus dasycarpus Turcz. is a perennial herbaceous plant of the Rutaceae family distributed in Heilongjiang, Gansu, and Anhui Provinces of China, as well as in North Korea, Mongolia, and Russia.
Seven species from the genus Dictamnus are distributed throughout Europe and North Asia, and only two species grow in China. One is Dictamnus dasycarpus Turcz., which can be found in many areas of China and has been recorded in the Chinese Pharmacopoeia. The other is Dictamnus angustifolius G. Don ex Sweet, which is only present in Xinjiang province and has been used as an alternative for Dictamnus dasycarpus locally for the treatment of rheumatism, bleeding, itching, jaundice, chronic hepatitis, and skin diseases.
The root bark of Dictamnus dasycarpus is a plant of the Rutaceae family, and its root bark is the main part used as a medicine, named 'Bai-Xian-Pi'. It is used to clear away heat, remove dampness, and dispel wind and also used for detoxification. In the standardized commercial trade, the dried root cortex is processed through methods including selecting, slicing, drying, sterilizing, fermenting, roasting, and steaming, which have been applied according to the standardized traditions of Chinese Medicine to achieve the best properties and efficiencies of the herb.
Origanum dictamnus (Lamiaceae family) is an endemic plant of the Greek island of Crete, widely used as a traditional medicine since antiquity, all over Europe. It is a rare perennial plant, endemic to the Greek island of Crete. It is a densely white-woolly subshrub that grows 20–30 cm high, with round leaves of velvety texture bearing lilac flowers surrounded by purple-pink bracts in summer. It grows on mountainous rocky cliffs and gorges, generally shaded or semi-shaded. This plant is also known as Cretan dittany, dittany of Crete, and has the synonym Dictamnus creticus.
While both plants share elements of the common name "dittany," they represent fundamentally different botanical lineages — one a member of Rutaceae (the citrus family) with a long TCM history, the other a member of Lamiaceae (the mint family) with a deeply rooted Mediterranean medicinal tradition. This article treats both in parallel, given that both are encountered in supplement commerce under the "dense fruit dittany" label.
The root bark of Dictamnus dasycarpus is the main part used as medicine, named 'Bai-Xian-Pi'. Commercial preparations available in the herbal supplement market include bulk dried root bark, water decoctions, and concentrated granule extracts. A typical concentrated granule product is formulated as 100 g of granules extracted from 500 g of raw herbs, with a suggested use of dissolving 2–3 scoops (2–4 grams) in a cup of hot water to make a tea drink. Standardized extract products identify key active marker compounds; active ingredient benchmarks reported in commercial extract products include fraxinellone (≥ 0.1 mg/g) and obakunone (≥ 0.5 mg/g).
In preclinical subchronic toxicology studies, dosages tested in mice ranged across several tiers: aqueous extract (CDAE) and ethanol extract (CDEE) were administered at varying dosages of 2.3, 4.6, or 9.2 g/kg/day by oral gavage in mice for 28 days in subchronic toxicity studies. These are animal study dosages only and do not correspond to human clinical dosing recommendations.
The above-ground parts (non-woody parts) have been traditionally used in Greece as a comminuted herbal substance for preparation of an infusion (locally called 'vrastari' in Crete, from the verb vrazo = to boil) or tincture by decoction for cutaneous use; in its native range, it is occasionally chewed crude against gingivitis, cough, and cold. Inflorescences and leaves have been added sometimes to sauces, salads, and vermouth.
Historical sources record specific preparations used by ancient physicians. Historical dosing records for Origanum dictamnus in powder form were 1–3 grams (½–1 dram); as a decoction in water or wine, 3–6 grams (1–2 drams); these doses were prescribed to promote delivery and expel a dead fetus. It should be noted that these are historical, not modern clinical, dosing references.
Dictamnus dasycarpus was first recorded in the Divine Farmer's Materia Medica, one of the foundational texts of classical Chinese medicine. Dictamni Cortex (DC, Bai-Xian-Pi in Chinese) is the root bark of Dictamnus dasycarpus Turcz. (family Rutaceae), which is extensively spread throughout China and has been used as a traditional Chinese herbal medicine for the treatment of rheumatism, jaundice, skin diseases, and chronic hepatitis with a long history.
Within the theoretical framework of Traditional Chinese Medicine (TCM), the herb is characterized by specific energetic properties. In terms of Traditional Chinese Medicine (TCM), Bai Xian Pi is classified as bitter, salty, and cold in property, and it influences the Spleen and Stomach channels. Its therapeutic actions are described as: dispelling wind and drying dampness; clearing heat and resolving toxicity.
Cortex Dictamni has received attention as a potential alternative medicine in the treatment of various diseases, such as inflammatory diseases, skin inflammation, tinea, eczema, scabies, rheumatic pain, and jaundice. Among the skin diseases traditionally treated with Dictamnus dasycarpus are atopic dermatitis, eczema, and psoriasis.
In ancient Greece, Origanum dictamnus, known as dittany of Crete, was valued for its medicinal properties and exported from the island as a sacred plant associated with deities like Artemis and Diktynna. The plant is referenced in Greek mythology and was known since antiquity for its therapeutic properties, mentioned by the Greek physician Hippocrates, the philosopher Aristotle, and the scholar and philosopher Theophrastus.
The physician Hippocrates (5th century BCE) recommended it for treating gastric complaints, tuberculosis, and as a poultice for wounds during his practice on the island of Cos. Dioscorides, in his 1st-century CE herbal De Materia Medica, described its use for wound healing, gastrointestinal relief, and to facilitate childbirth, including infusions in wine for postpartum cleansing.
During the medieval period in Europe, dittany was imported and incorporated into wound salves and topical remedies, drawing on ancient Greek traditions to treat injuries, expel foreign objects like arrows or thorns, and address plague-related sores during outbreaks like the Black Death.
Dense fruit dittany (Cretan dittany) has a long history of use in traditional Mediterranean herbal medicine, particularly in Crete, where it was considered a panacea for various ailments, including inflammation. Historical texts and folk practices often reference the use of dittany infusions, poultices, and extracts for treating wounds, digestive complaints, and inflammatory conditions.
Infusions and decoctions of the aerial parts were used to alleviate stomach disorders such as dyspepsia and sensations of fullness, as well as to provide relief from cough and mild respiratory issues like sore throat and tonsillitis. In Cretan folk medicine, root salves address sciatica, while the plant is noted for easing hypertension and facilitating childbirth.
"Dictamnus" traditions, broadly construed, show that the transmission of traditional knowledge about materia medica over 26 centuries represents remarkable levels of development and innovation.
More than 200 compounds have been isolated and identified from Dictamnus dasycarpus, including alkaloids and their glycosides, terpenoids and their derivatives, and phenylpropanoids.
The root barks contain limonoids, quinoline alkaloids, sesquiterpenes, coumarins, flavonoids, steroids, and triterpenes. As the characteristic and active constituents in Dictamnus species, limonoids and quinoline alkaloids possess wide-reaching biological activities, including anti-cancer, anti-inflammatory, anti-microbial, anti-platelet-aggregation, vascular-relaxing, anti-insect, anti-HIV, immunosuppressing, neuroprotective, antioxidant, and mutagenic activities.
Specific individual compounds isolated and characterized by spectroscopic methods from the root bark methanol extract include: kihadanin D, obacunone, kihadanin A, kihadanin B, kihadanin C, limonin, evodol, fraxinellone, furo[2,3-b]quinolin-4-ol, preskimmianine, ifflaiamine, dictamnol, naringenin, diosmetin, wogonin, scopoletin, cleomiscosin A, apocynin, and methyl pyroglutamate.
Fraxinellone and obakunone are among the most studied limonoids and serve as quality-control markers for commercial preparations. Phytochemical investigations have indicated that quinoline alkaloids and limonoids are the major bioactive components, with potential cytotoxic, neuroprotective, anti-inflammatory, antimicrobial, anti-platelet-aggregation, and vascular-relaxing activities. The pharmacological activity of the species primarily stems from quinoline alkaloids and limonoids, which predominantly accumulate in the taproots.
Additionally, phytochemical investigation of the ethyl acetate extracts from root barks of Dictamnus dasycarpus has led to the isolation of novel compounds, named dasycarpusenester A, dasycarpusester B, and dasycarpusacid.
A variety of compounds, including flavonoids, lipids, and terpenoids (mainly carvacrol and thymol) have been identified from Origanum dictamnus. A more comprehensive phytochemical analysis of the methanol extract resulted in a broader profile: phytochemical investigations resulted in the isolation of forty compounds belonging to the classes of terpenes, resorcinol derivatives, flavonoids, depsides, neolignans, and jasmonates.
The essential oil fraction has been characterized with particular precision. The main constituents of O. dictamnus essential oil identified by GC–MS analysis were carvacrol (52.2%), γ-terpinene (8.4%), p-cymene (6.1%), linalool (1.4%), and caryophyllene (1.3%).
The aqueous decoction (prepared in the traditional manner of drinking as herbal tea) was found to contain its own distinct set of compounds. Ten secondary metabolites were isolated and elucidated for the first time from the drinkable decoction: carvacrol, β-sitosterol, uvaol, ursolic acid, rosmarinic acid, lithospermic acid, ferulic acid, caffeic acid, p-coumaric acid, and apigenin-7-O-glucoside. The samples showed a high total phenolic content (185.5–139.7 mg CAE/g) and an interesting antibacterial profile against Gram-positive and Gram-negative human pathogenic microorganisms.
The known bioactivities of O. dictamnus essential oil are mainly attributed to carvacrol, a phenolic compound which is the main constituent of the volatile fraction.
Multiple studies have reported that Cortex Dictamni exhibits various functional properties, including anti-inflammatory, antioxidant, anti-allergic, neuroprotective, hepatoprotective, and anti-microbial activities. The anti-inflammatory mechanism for atopic-type disease involves immune signaling: research has demonstrated that Dictamnus dasycarpus Turcz. attenuates collagen-induced rheumatoid arthritis in DBA/1J mice through inhibiting the IL-17 signaling pathway.
Some modern studies have identified that Origanum dictamnus contains phenolic compounds, such as carvacrol and thymol, which have demonstrated antimicrobial activity in vitro. However, these studies are limited and often use isolated compounds or extracts at concentrations not typically achieved through traditional use.
Origanum dictamnus L. is an aromatic plant belonging to the Lamiaceae family. A 2025 study evaluated how the essential oil (EO) showed inhibitory activity against enzymes associated with Central Nervous System disorders and human metabolism. The EO was analyzed by GC/MS. Enzyme inhibitory activity against cholinesterases, tyrosinase, α-amylase, α-glucosidase, and lipase were investigated. The EO was mainly composed of carvacrol and p-cymene. The enzymatic assays showed inhibitory activities dependent on EO concentration.
A 2026 preclinical study examined functional food potential: Origanum dictamnus L. (dittany of Crete), traditionally used as an herbal beverage valued for its digestive properties and aromatic profile, was studied to evaluate its potential as a functional food ingredient by combining detailed phytochemical profiling with assessment of gastrointestinal activity. The infusion demonstrated spasmolytic activity, modulating both phasic and tonic intestinal contractions. These effects were benchmarked against scopolamine and further explored through receptor inhibition assays. The water-soluble constituents were responsible for the spasmolytic activity. Adrenergic system activation and neurogenic inhibition were identified as possible involved mechanisms.
In recent years, extensive research has been conducted on the functional properties of Cortex Dictamni. Cortex Dictamni has a huge potential to be an alternative medicine in the treatment of various diseases, such as inflammatory diseases, skin inflammation, tinea, eczema, scabies, rheumatic pain, and jaundice, and it receives greater attention due to its pharmacological effects.
Preclinical (animal) research has investigated allergic skin responses. Studies in rodent models have examined the herb's effect on allergic contact dermatitis and delayed hypersensitivity. Modern pharmacological research has confirmed its varieties of pharmacological properties, such as anti-inflammatory, anti-bacterium, anti-delayed allergy, protection of the cardiovascular system, anti-cancer, and protection of the liver. However, all evidence in dermatology for Dictamnus dasycarpus remains preclinical (in vitro and animal models); no controlled human clinical trials have been identified in the peer-reviewed literature.
Animal model research has investigated rheumatoid arthritis. Cortex Dictamni has been used as a traditional Chinese herbal medicine for the treatment of rheumatism, jaundice, skin diseases, and chronic hepatitis with a long history. Preclinical data in rodent models of collagen-induced arthritis supports an IL-17-pathway dependent anti-inflammatory mechanism, as noted above. Evidence quality: animal/in vitro only; no human clinical trials identified.
Cytotoxicity studies on isolated compounds have been conducted. Cytotoxicities of isolated compounds were tested, and results indicated that kihadanin D (a novel limonoid) exhibited cytotoxicities against three human cancer cell lines MDA-MB-231, A549, and HT29. Evidence quality: in vitro, cell-line studies only. No clinical evidence exists.
Current studies have shown that the extracts, the essential oil, as well as their active principles possess several pharmacological properties, like antimicrobial, antioxidant, and anti-ulcer ones. O. dictamnus essential oil and its main components were effective against Staphylococcus aureus and other organisms. The main O. dictamnus essential oil constituents showed significant antimicrobial activity against common food spoilage and pathogenic bacteria. Studies have shown a high total phenolic content (185.5–139.7 mg CAE/g) and an interesting antibacterial profile against Gram-positive and Gram-negative human pathogenic microorganisms. Evidence quality: predominantly in vitro. No human clinical trials of antimicrobial efficacy have been identified.
The essential oil (EO) of O. dictamnus is known for its antioxidant, antimicrobial, and antiproliferative activities. Multiple phytochemical analyses confirm robust antioxidant potential, attributable particularly to rosmarinic acid, caffeic acid, and the phenolic monoterpenes carvacrol and thymol present in the plant's extracts and essential oil. Evidence quality: in vitro antioxidant assays only; no controlled human clinical trials identified.
Origanum dictamnus is widely used as an herbal tea (decoction) and traditional medicine since antiquity in Greece (island of Crete). The aerial parts of the plants are used in various preparations for stomach and gastric disorders, as well as for the maintenance of good health. Due to its wide application as a traditional herbal medicinal product, there is an increasing interest in modern pharmacology.
An increasing number of chemical and pharmacological studies have been reported recently, some of which strongly support its traditional medicinal uses against various illnesses such as sore throat, cough, and gastric ulcer. The preclinical spasmolytic data (cited above) from the 2026 study is among the most mechanistically specific evidence for gastrointestinal effects. Evidence quality: traditional use recognized by regulatory bodies; preclinical data (animal and in vitro) supportive, but no randomized controlled trials in humans have been identified.
The scientific evidence supporting anti-inflammatory effects of Origanum dictamnus remains limited. While some in vitro studies have identified potential antioxidant and anti-inflammatory properties in extracts, these findings have not been extensively validated in clinical settings. Most of the support for its use in treating inflammation comes from traditional herbal medicine practices, not from rigorous, peer-reviewed clinical trials.
The ancient physician Hippocrates and later Dioscorides mentioned dittany as an effective remedy for wound healing and as an antiseptic. Its leaves were often applied directly to wounds, or made into poultices and ointments. The plant contains essential oils, such as carvacrol and thymol, which are known to have antimicrobial properties, and this may have contributed to its perceived effectiveness in traditional settings. However, scientific studies specifically investigating the wound-healing properties of dense fruit dittany are limited. While some in vitro and animal studies have demonstrated antimicrobial and anti-inflammatory effects of extracts from Origanum dictamnus, direct clinical evidence remains absent.
Based on pharmacological study data, O. dictamnus essential oil could be used as a supplement for management of metabolic and neurological disease. The 2025 in vitro/in silico study referenced above found inhibitory activity against cholinesterases (relevant to Alzheimer's-type neurodegeneration), tyrosinase, α-amylase, α-glucosidase, and lipase. Evidence quality: in vitro and in silico only; no human clinical studies on neurological or metabolic endpoints have been identified.
The European Medicines Agency's Committee on Herbal Medicinal Products (HMPC) has formally assessed Origanum dictamnus. The HMPC recognized in a monograph for the herbal drug the status of "traditional use" due to its long-standing use. However, no clinical studies on efficacy of the herbal drug and/or preparations therefrom are available to date. This represents the highest-quality regulatory determination of the plant's evidence status for the European Union.
The most significant documented safety concern for Dictamnus dasycarpus is liver injury. The root bark of Dictamnus dasycarpus Turcz., Dictamni Cortex (DC), is widely used in the treatment of skin inflammation, eczema, rubella, rheumatism, and gynecological inflammation. Unexpectedly, there are some cases of liver injury after the administration of DC. Two patients from the UK developed acute hepatitis after taking herbal preparations containing DC for the treatment of chronic skin disease.
In China, liver injury caused by DC occurs more frequently, such as in Qingdai Pill, Keyin Pill, and Zhixue Capsule, all of which can lead to hepatotoxicity. Polygoni multiflori and Dictamnus dasycarpus were the most frequent causative agents inducing liver injury identified in a Korean study.
Subchronic animal studies have further characterized this risk: ALT and AST were significantly increased in the high-dose groups (aqueous and ethanol extract) compared to the control group. Meanwhile, the absolute and relative liver weights and liver/brain ratio were significantly elevated, and histological examination of liver demonstrated cellular enlargement or nuclear shrinkage.
The responsible toxic compounds have been identified: dictamnine, obakunone, and fraxinellone may be the possible toxic components in Cortex Dictamni, with dictamnine as the most potentially hepatotoxic component, whose potential hepatotoxicity mechanism may be associated with cell apoptosis. Studies suggest that both aqueous and ethanol extracts have potential hepatotoxicity, and that the alcohol extraction process could increase toxicity.
Results from experimental models have indicated that D. dasycarpus can lead to abnormal liver injury under immune stress states. One study found that ethanol extracts at the dose of 60 g/kg caused severe hepatocellular necrosis over 24 h, in a dose- and time-dependent manner.
There are reports on the toxic hepatitis and phototoxic effect of Dictamnus species, and the related research needs to be further studied. Phototoxic effects are consistent with the furoquinoline alkaloid and furanocoumarin content characteristic of the Rutaceae family.
No significant direct clinical toxicity has been documented for Origanum dictamnus used in traditional preparations (infusions, decoctions) at typical herbal use levels. There is a lack of robust clinical trials in humans specifically examining dense fruit dittany for infection treatment. While there is a strong traditional basis for its use, scientific validation is limited and primarily restricted to laboratory studies. The traditional evidence is notable, but the overall quality and quantity of scientific evidence supporting its efficacy remain modest.
Chinese herbs, including Bai Xian Pi, are generally used with caution, and professional healthcare advice is recommended. Chinese herbs are generally combined in herbal formulas to work effectively together for desired results and to minimize potential side effects.
Health conditions that Dense fruit dittany may help support.
Body systems that Dense fruit dittany may help support.
Go back